At Worldwide Clinical Trials (WCT), we are a therapeutically focused CRO with multi-national presence and capabilities. Our heritage and focus is in cardiovascular and central nervous system – the senior medical team are pioneers in these categories. They have helped to develop the infrastructure, strategies and science behind today’s approach to clinical research.  WCT’s rich and successful history developed through the integration of leading CRO organizations has resulted in creating the world-class clinical research organization that WCT is today.

Founded in 1986 by Dr. Neal R. Cutler and his team, Worldwide Clinical Trials, Inc. began as an investigational site before expanding to become a global CRO in 1995.

Known for developing several revolutionary and innovative drug development techniques such as the “Bridging” and “Dynabridge” (CSF) studies, Dr. Cutler became a champion of the need for quality in conducting large clinical trials, particularly in the area of accurate and sensitive psychiatric ratings and neuropsychological assessments. These innovations increased the quality, safety and the speed of drug development.

WCT Europe

A milestone in WCT’s developing reputation as a world-leader in large-scale, multinational cardiovascular clinical outcome trials was the integration of Nottingham Clinical Research Limited (NCRL), based in the United Kingdom.

NCRL was founded in 1988 by the current Managing Director, Dr. Allan Skene. Dr. Skene has over 25 years' experience of research and teaching of statistical methodology and statistical computing. He serves regularly on Data and Safety Monitoring Boards for international trials, and his research focus combined with his flexibility of approach often results in expedited solutions to complex problems.

With over twenty years' experience in the conduct of very large global clinical trials, Dr. Skene and his team occupy an unrivalled position as the global centre of excellence in the conduct of this type of study. The experience and expertise of our European project management team in the coordination and conduct of these large trials is unparalleled in the industry.

WCT Central / Eastern Europe and Russia

The foundation of Worldwide Clinical Trials' presence in Russia and Eastern Europe is a story of success built through the leadership, innovation, hard work, and perseverance that created Evidence Clinical and Pharmaceutical Research, LLC and Mediquest, now both integral parts of the WCT organization. 

Evidence began in 1989, when only a handful of Eastern European medical professionals had been exposed to randomized controlled clinical trials.  One of them was Dr. Varshavsky, a St. Petersburg cardiologist, who was invited by the European Myocardial Infarction Project (EMIP) to serve as National Coordinator for Russia on a clinical trial sponsored by the European Union. This experience convinced Dr. Varshavsky and his colleagues that the time had come for Russia to adopt the Good Clinical Practice standards.

The small group of dedicated professionals began working on implementing international industry standards in Russia, and their efforts paid off in 1990, when the Guideline for Good Clinical Practice (GCP) and ICH Harmonized Tripartite Guideline were translated into Russian language and introduced to regulators and medical professionals. Dr. Varshavsky’s organization became the first CRO to conduct clinical trial research to GCP standards in Russia, and later in Ukraine and Georgia; and the first CRO to conduct a multinational clinical study in Russia.

MediQuest is a Serbia based Contract Research Organization (CRO) providing specialized clinical development services to biopharmaceutical companies and organizations. MediQuest has over 30 years of experience in conducting clinical studies in Central and Eastern Europe. We apply occidental standards to fully capture the potential of untapped patient pools through the excellence of our highly qualified local staff, our knowledge of the cultures and regulatory environments, and the exceptional performance of our proven investigator networks.

Today, Worldwide Clinical Trials leads the field in the Russian Federation and the Commonwealth of Independent States, and has established a solid presence as the leading CRO in Eastern Europe.

WCT Americas

To expand WCT’s reputation as a world-leader in clinical trial monitoring and study management the Clincial Studies Management Group (CSMG) was integrated into WCT. CSMG provides Biotech and Pharmaceutical sponsors with excellence in clinical trial monitoring and study management services for all four phases of the clinical trial process. Founded in 1991 by Annie Y. Clark, President and CEO, CSMG currently employs senior-level clinical research associates with therapeutic expertise strategically located to conduct management and monitoring. CSMG forms close working relationship with sponsors and enjoys a 98% repeat business ratio.

In Latin America, to meet the clinical research needs, WCT has developed clinical trial operations led by professionals with more than 15 years of clinical research experience. Based in Buenos Aires, Argentina, WCT follows Good Clinical Practices, National Drug Agency rules, USA FDA regulatory guidance and the European Union Directive. WCT has the capability to conduct trials in Argentina, Chile, Uruguay, Mexico and Brazil, including clinical operations (medical and site monitoring), regulatory approvals and management, Pharmacovigilance, and drug supply management.